相似文献
1
SMPDL3A links cholesterol metabolism to the cGAS-STING pathway.
Immunity. 2023 Nov 14;56(11):2459-2461. doi: 10.1016/j.immuni.2023.10.015.
2
SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing.
Immunity. 2023 Nov 14;56(11):2492-2507.e10. doi: 10.1016/j.immuni.2023.10.001. Epub 2023 Oct 26.
3
cGAMP-activated cGAS-STING signaling: its bacterial origins and evolutionary adaptation by metazoans.
Nat Struct Mol Biol. 2023 Mar;30(3):245-260. doi: 10.1038/s41594-023-00933-9. Epub 2023 Mar 9.
4
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases.
Arch Pharm Res. 2023 Jun;46(6):500-534. doi: 10.1007/s12272-023-01452-3. Epub 2023 Jun 24.
5
Advances in structure-guided mechanisms impacting on the cGAS-STING innate immune pathway.
Adv Immunol. 2023;159:1-32. doi: 10.1016/bs.ai.2023.08.001. Epub 2023 Sep 12.
6
Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
J Virol. 2016 Jun 10;90(13):5915-27. doi: 10.1128/JVI.00500-16. Print 2016 Jul 1.
7
DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway.
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12196-12201. doi: 10.1073/pnas.1708744114. Epub 2017 Oct 30.
8
The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.
Front Immunol. 2021 Apr 29;12:682736. doi: 10.3389/fimmu.2021.682736. eCollection 2021.
9
Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway.
Immunity. 2020 Jul 14;53(1):43-53. doi: 10.1016/j.immuni.2020.05.013.
10
The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism.
Diabetes. 2019 Jun;68(6):1099-1108. doi: 10.2337/dbi18-0052.
引用本文的文献
1
Camouflaged membrane-bridged radionuclide/Mn single-atom enzymes target lipid metabolism disruption to evoke antitumor immunity.
Mil Med Res. 2025 Sep 19;12(1):59. doi: 10.1186/s40779-025-00647-7.
2
STING inhibits the progression of esophageal squamous cell carcinoma by suppressing CPT1A-mediated fatty acid β-oxidation.
Acta Pharmacol Sin. 2025 May 20. doi: 10.1038/s41401-025-01581-z.
3
Deciphering cGAS-STING signaling: implications for tumor immunity and hepatocellular carcinoma.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 7. doi: 10.1007/s00210-025-04240-6.
4
Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies.
Cell Commun Signal. 2025 Apr 7;23(1):171. doi: 10.1186/s12964-025-02169-0.
5
Multiomics analysis provides insights into musk secretion in muskrat and musk deer.
Gigascience. 2025 Jan 6;14. doi: 10.1093/gigascience/giaf006.
6
Immune genes involved in synaptic plasticity during early postnatal brain development contribute to post-stroke damage in the aging male rat brain.
Biogerontology. 2025 Feb 18;26(2):60. doi: 10.1007/s10522-025-10203-4.
7
Cholesterol restriction primes antiviral innate immunity via SREBP1-driven noncanonical type I IFNs.
EMBO Rep. 2025 Jan;26(2):560-592. doi: 10.1038/s44319-024-00346-9. Epub 2024 Dec 12.
8
The crucial roles and research advances of cGAS‑STING pathway in liver diseases.
Ann Med. 2024 Dec;56(1):2394588. doi: 10.1080/07853890.2024.2394588. Epub 2024 Aug 25.
本文引用的文献
1
SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing.
Immunity. 2023 Nov 14;56(11):2492-2507.e10. doi: 10.1016/j.immuni.2023.10.001. Epub 2023 Oct 26.
2
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway.
Annu Rev Biochem. 2022 Jun 21;91:599-628. doi: 10.1146/annurev-biochem-040320-101629. Epub 2022 Mar 14.
3
The cGAS-STING pathway as a therapeutic target in inflammatory diseases.
Nat Rev Immunol. 2021 Sep;21(9):548-569. doi: 10.1038/s41577-021-00524-z. Epub 2021 Apr 8.
4
Systemic Immunometabolism: Challenges and Opportunities.
Immunity. 2020 Sep 15;53(3):496-509. doi: 10.1016/j.immuni.2020.08.012.
5
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.
Cell. 2015 Dec 17;163(7):1716-29. doi: 10.1016/j.cell.2015.11.045. Epub 2015 Dec 10.
6
Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.
Nat Chem Biol. 2014 Dec;10(12):1043-8. doi: 10.1038/nchembio.1661. Epub 2014 Oct 26.
7
Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages.
J Biol Chem. 2014 Nov 21;289(47):32895-913. doi: 10.1074/jbc.M114.612341. Epub 2014 Oct 6.
8
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.
Science. 2013 Feb 15;339(6121):786-91. doi: 10.1126/science.1232458. Epub 2012 Dec 20.
9
Liver x receptors in atherosclerosis and inflammation.
Circ Res. 2011 Apr 15;108(8):996-1001. doi: 10.1161/CIRCRESAHA.110.226878.
10
MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.
Eur J Hum Genet. 2005 Mar;13(3):314-20. doi: 10.1038/sj.ejhg.5201323.
Zotero 插件